Samantha Marie Watts, PA-C in Fort Worth, TX - Medicare

Samantha Marie Watts, PA-C is a medicare enrolled "Physician Assistant" physician in Fort Worth, Texas. Her current practice location is 1250 8th Ave Ste 200, Fort Worth, Texas. You can reach out to her office (for appointments etc.) via phone at (817) 912-8240.

Samantha Marie Watts is licensed to practice in Texas (license number PA12869) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1043877384.

Contact Information

	Samantha Marie Watts, PA-C
	1250 8th Ave Ste 200, Fort Worth, TX 76104-4158
	(817) 912-8240
	Not Available

Physician's Profile

Full Name	Samantha Marie Watts
Gender	Female
Speciality
Experience	Years
Location	1250 8th Ave Ste 200, Fort Worth, Texas
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Samantha Marie Watts attended and graduated from in

NPI Data:

NPI Number: 1043877384
Provider Enumeration Date: 05/22/2019
Last Update Date: 05/30/2023

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Samantha Marie Watts such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043877384	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208M00000X	Hospitalist	193400000X (Texas)	Secondary
363A00000X	Physician Assistant	PA12869 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Samantha Marie Watts is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Samantha Marie Watts, PA-C 3408 Grants Lndg, Fort Worth, TX 76179-3853 Ph: (435) 659-9821	Samantha Marie Watts, PA-C 1250 8th Ave Ste 200, Fort Worth, TX 76104-4158 Ph: (817) 912-8240

News Archive

Does hormone treatment predispose patients to breast cancer?

Breast cancer, the leading cause of death among women in France, is the most commonly occurring cancer in women.

Epilepsy 'treatment gap' in Sierra Leone a result of stigma, lack of resources, experts say

In Sierra Leone, "one of Africa's poorest countries, ... scarce health care resources and the stigma surrounding epilepsy add up to a 'treatment gap' of more than 90 percent - meaning that fewer than 10 percent of the estimated 60,000 to 100,000 Sierra Leoneans with epilepsy are getting the treatment they need," the New York Times reports.

Clinical study to investigate Cytori's adipose-derived cell therapy in patients with heart failure

Timothy Henry, M.D. of the Minneapolis Heart Institute Foundation treated the first patient in the ATHENA study, injecting the patient's own stem cells into the heart to restore blood flow and help regenerate heart muscle. Henry, the Foundation's Director of Research is co-principal investigator of the ATHENA study sponsored by Cytori Therapeutics.

PSA levels accurately predict prostate cancer risk in African-American men

PSA levels appear to be more predictive of three year prostate cancer risk in African-American men compared with Caucasian men with a family history of prostate cancer, according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

Etravirine reduces HIV viral loads when taken with Prezista

The experimental antiretroviral drug etravirine, made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals, greatly reduces HIV viral loads in people with a history of drug resistance when taken in combination with Tibotec's antiretroviral Prezista, according to two studies published Saturday in the journal The Lancet.

Samantha Marie Watts, PA-C - Medicare in Fort Worth, TX